47th Annual Meeting of the American-Society-of-Hematology Conference

related documents

• A Novel Inherited Platelet Function Disorder Involving the Thromboxane A2 Pathway of Platelet Activation.  Conference Paper
• A Novel Thrombin Fluorogenic Substrate of High Affinity, Catalytic Efficiency and Selectivity.  Conference Paper
• A multicenter, randomized, controlled clinical pilot trial of the feasibility of an intensive RBC transfusion policy for patients with acute leukemia treated with induction chemotherapy or stem cell transplant.  Conference Paper
• A new model for predicting venesection therapy requirements in hereditary hemochromatosis using non-invasive liver iron concentration measurement  Conference Paper
• A prospective cohort study of the epidemiology of symptomatic venous thromboembolism (VTE) after isolated leg fractures distal to the knee without thromboprophylaxis.  Conference Paper
• A revisit of the criteria to define remission in patients with idiopathic thrombocytopenia undergoing splenectomy.  Conference Paper
• Age significantly influences presentation and patterns of care in patients with newly diagnosed diffuse large cell lymphoma (DLCL): Collective data from 5 centers participating in the National Comprehensive Center Network (NCCN) NHL Outcomes Project.  Conference Paper
• Anti-Xa levels and renal function: Analysis of the first 32 patients in the tinzaparin in renal insufficiency for venous thromboembolism study  Conference Paper
• Anticoagulant Heparan Sulfate Mediates Antithrombin Amelioration of Leukocyte-Endothelial Interactions in Sepsis.  Conference Paper
• Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network  Conference Paper
• Does thromboprophylaxis reduce mortality in medical patients? A systematic review and meta-analysis of randomized controlled tials  Conference Paper
• Existing warfarin therapy in long-term care facilities maybe inadequate  Conference Paper
• Exposure of Anion Binding Exosite I of Thrombin Is Required and Sufficient for Timely Cleavage and Activation of Factor V and Factor VIII.  Conference Paper
• Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: The randomized APOLLO study.  Conference Paper
• Hemolytic uremic syndrome is an immune mediated disease: Role of anti-CD36 antibodies.  Conference Paper
• Insights into Disturbed Hemostasis in the Quebec Platelet Disorder Using Thromboelastography, Blood Clots Formed at Low Shear, and Perfusion Studies of Fibrinolysis.  Conference Paper
• Intravenous gamma globulin does not increase RNA of FcgRIIb in purified human monocytes.  Conference Paper
• Leukemia-related gene expression of bone marrow cells from patients with Shwachman-Diamond syndrome at the pre-leukemic phase.  Conference Paper
• Low molecular weight heparin and bleeding in patients with severe renal failure: A meta-analysis  Conference Paper
• Maintenance therapy with thalidomide/prednisone post autologous stem-cell transplant for patients with multiple myeloma elevates D-dimer and possibly factor VIII levels.  Conference Paper
• Mechanisms of static and shear-induced platelet adhesion: Differences in the adhesion supported by MMRN1 comparisons with other beta 3 integrin ligands.  Conference Paper
• MicroRNA Expression Profiling in Sorted AML Subpopulations: A Possible Role for miR-155/BIC in Stem Cell Maintenance and Leukemogenesis.  Conference Paper
• Notch Activation Converts B Cells into a T Cell Fate at the Earliest Stages of B Cell Committed Progenitors.  Conference Paper
• Outcomes of previously untreated older patients with multiple myeloma (MM) over time: An analysis of 3 consecutive trials conducted by the NCICCTG, 1983-2003.  Conference Paper
• Patient Characteristics in CD 20+ and CD 20− Adult Acute Lymphoblastic Leukemia (ALL): A Single Institution Analysis.  Conference Paper
• PedsQL (TM) and EuroQol most responsive measures to change in health-related quality of life in children with Hodgkin's disease.  Conference Paper
• Pitfalls in interpreting platelet function tests in thrombocytopenic patients referred by a hematologist for diagnostic testing: Results from a single center prospective study.  Conference Paper
• Potential impact of pathologic review on therapy in non-Hodgkin's lymphoma (NHL): Analysis from the national comprehensive cancer network (NCCN) NHL outcomes project  Conference Paper
• Pregnancy in thalassemia patients and their partners in a Canadian population.  Conference Paper
• Prognostic Significance of Biochemical Markers of Bone Metabolism in Patients with Bone Lesions from Multiple Myeloma (MM).  Conference Paper
• Quantitiative Analysis of Roughness of Catheters by Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM).  Conference Paper
• Rates of clinically apparent venous thromboembolism and death resulting from pulmonary embolism among unselected hospitalized acutely ill medical patients versus rates predicted from clinical studies.  Conference Paper
• Relapse patterns and subsequent outcomes of patients treated on the NCICCTG HD.6 (ECOG JHD06) randomized trial evaluating ABVD alone in patients with limited stage Hodgkin lymphoma (HL).  Conference Paper
• Rituximab for the treatment of adults with ITP: A systematic review  Conference Paper
• Sequential analysis of the alpha- and beta-globin gene expressions during erythropoietic differentiation from primate ES cells.  Conference Paper
• Should high-risk patients with chronic atrial fibrillation and those with coronary artery disease receive combined aspirin-oral anticoagulant therapy or oral anticoagulant therapy alone? A systematic review and meta-analysis  Conference Paper
• Systematic Review of Randomized Controlled Trials of Prophylactic Clotting Factor Concentrate in Hemophilia.  Conference Paper
• The HPA-15 (Gov) Platelet Alloantigen System: Allele Frequencies in the Canadian Population.  Conference Paper
• The Worcester Venous Thromboembolism Study: A Population Based Perspective of Venous Thromboembolism Attack Rates.  Conference Paper
• Thrombin Aptamer HD1 Inhibits Prothrombin Activation by Binding Proexosite 1 on Prothrombin.  Conference Paper
• Thromboembolism in children with sarcoma.  Conference Paper
• Thromboprophylaxis after orthopaedic surgery with an oral, direct factor Xa inhibitor: Pooled results of two phase Iib clinical trials.  Conference Paper
• Towards a conceptual framework for diagnosis of heparin-induced thrombocytopenia (HIT)  Conference Paper
• Treatment of thrombotic thrombocytopenic purpura using solvent detergent treated plasma.  Conference Paper
• Trends in AIDS-Associated Cancers among Patients Attending a Palliative Care Service in Uganda in the ’Pre-HAART’ Era, 1994–2002.  Conference Paper
• Undetected factor VIII level in a type III von Willebrand disease (vWD) patient masquerading as severe hemophilia  Conference Paper
• Upper Extremity Deep Vein Thrombosis - Incidence, Risk Factors, and Management. The Worcester Venous Thromboembolism Study.  Conference Paper
• Use of low dose oral vitamin K in the treatment of patients with INR values of more than 10.0.  Conference Paper
• VENUS - A study to validate centrally adjudicated venous ultrasound against venography after major orthopaedic surgery.  Conference Paper
• Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients with Heart Failure (NYHA Class III or IV): Findings from IMPROVE.  Conference Paper
• Zinc2+ Promotes Heparin Binding to Fibrin and Subsequent Formation of Ternary Heparin-Thrombin-Fibrin Complexes.  Conference Paper